| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
three prime repair exonuclease 1 | 0.517 | 0.808 | 0.58 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | ||||||||
|
complement C3d receptor 2 | 0.556 | 0.654 | 4.7E-19 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1998 | 1998 | ||||||||
|
ELAV like RNA binding protein 3 | 0.705 | 0.385 | 0.77 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2012 | 2012 | ||||||||
|
galactokinase 1 | 0.682 | 0.346 | 1.0E-05 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
galactose-1-phosphate uridylyltransferase | 0.612 | 0.654 | 2.1E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1991 | 1991 | |||||||||
|
chromosome 17 open reading frame 97 | 0.548 | 0.577 | 4.8E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
microRNA 144 | 0.500 | 0.769 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | |||||||||
|
ras related dexamethasone induced 1 | 0.666 | 0.654 | 3.9E-02 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | ||||||||
|
plexin B1 | 0.621 | 0.692 | 3.8E-04 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2017 | 2017 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
V-set immunoregulatory receptor | 0.573 | 0.654 | 0.76 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
solute carrier family 2 member 5 | 0.647 | 0.500 | 3.6E-10 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
ATR interacting protein | 0.666 | 0.692 | 2.0E-05 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | ||||||||
|
cyclin dependent kinase inhibitor 3 | 0.514 | 0.769 | 1.9E-03 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1999 | 2016 | ||||||||
|
lymphatic vessel endothelial hyaluronan receptor 1 | 0.587 | 0.731 | 4.7E-07 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2001 | 2011 | ||||||||
|
clusterin | 0.426 | 0.885 | 7.8E-05 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2005 | 2015 | ||||||||
|
jagged canonical Notch ligand 1 | 0.429 | 0.808 | 1.00 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1994 | 2017 | ||||||||
|
protein phosphatase 2 phosphatase activator | 0.480 | 0.846 | 0.99 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2017 | 2019 | ||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2009 | 2017 | ||||||||
|
TIAM Rac1 associated GEF 1 | 0.579 | 0.731 | 0.96 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 2012 | 2013 | ||||||||
|
fibroblast growth factor receptor 4 | 0.490 | 0.769 | 7.2E-13 |
|
group | 0.030 | None | 0.667 | 3 | 0 | 2010 | 2019 | ||||||||
|
caudal type homeobox 2 | 0.458 | 0.769 | 0.53 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2004 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
group | 0.040 | None | 0.750 | 4 | 0 | 2013 | 2017 |